Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What's new in hemorrhagic shock?

Literature DB >> 25608924

What's new in hemorrhagic shock?

Krisztián Tánczos¹, Márton Németh, Zsolt Molnár.

Abstract

Entities: Disease

Mesh：

Year: 2015 PMID： 25608924 DOI： 10.1007/s00134-015-3658-8

Source DB: PubMed Journal: Intensive Care Med ISSN： 0342-4642 Impact factor: 17.440

× No keyword cloud information.

18 in total

Review 1. Practical application of point-of-care coagulation testing to guide treatment decisions in trauma.

Authors: Herbert Schöchl; Wolfgang Voelckel; Alberto Grassetto; Christoph J Schlimp
Journal: J Trauma Acute Care Surg Date: 2013-06 Impact factor: 3.313

2. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.

Authors: Carl J Hauser; Kenneth Boffard; Richard Dutton; Gordon R Bernard; Martin A Croce; John B Holcomb; Ari Leppaniemi; Michael Parr; Jean-Louis Vincent; Bartholomew J Tortella; Jeannett Dimsits; Bertil Bouillon
Journal: J Trauma Date: 2010-09

Review 3. Clinical review: Fresh frozen plasma in massive bleedings - more questions than answers.

Authors: Bartolomeu Nascimento; Jeannie Callum; Gordon Rubenfeld; Joao Baptista Rezende Neto; Yulia Lin; Sandro Rizoli
Journal: Crit Care Date: 2010-01-28 Impact factor: 9.097

4. Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy.

Authors: M Brenni; M Worn; M Brüesch; D R Spahn; M T Ganter
Journal: Acta Anaesthesiol Scand Date: 2009-10-26 Impact factor: 2.105

5. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study.

Authors: Karen A Zink; Chitra N Sambasivan; John B Holcomb; Gary Chisholm; Martin A Schreiber
Journal: Am J Surg Date: 2009-05 Impact factor: 2.565

6. The relationship of blood product ratio to mortality: survival benefit or survival bias?

Authors: Christopher W Snyder; Jordan A Weinberg; Gerald McGwin; Sherry M Melton; Richard L George; Donald A Reiff; James M Cross; Jennifer Hubbard-Brown; Loring W Rue; Jeffrey D Kerby
Journal: J Trauma Date: 2009-02

7. Central venous oxygen saturation and carbon dioxide gap as resuscitation targets in a hemorrhagic shock.

Authors: M Németh; K Tánczos; G Demeter; D Erces; J Kaszaki; A Mikor; Z Molnár
Journal: Acta Anaesthesiol Scand Date: 2014-03-18 Impact factor: 2.105

8. Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage.

Authors: Sirat Khan; Ross Davenport; Imran Raza; Simon Glasgow; Henry D De'Ath; Pär I Johansson; Nicola Curry; Simon Stanworth; Christine Gaarder; Karim Brohi
Journal: Intensive Care Med Date: 2014-12-02 Impact factor: 17.440

Review 9. Clinical review: Canadian National Advisory Committee on Blood and Blood Products--Massive transfusion consensus conference 2011: report of the panel.

Authors: Walter H Dzik; Morris A Blajchman; Dean Fergusson; Morad Hameed; Blair Henry; Andrew W Kirkpatrick; Teresa Korogyi; Sarvesh Logsetty; Robert C Skeate; Simon Stanworth; Charles MacAdams; Brian Muirhead
Journal: Crit Care Date: 2011-12-08 Impact factor: 9.097

10. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine.

Authors: Maurizio Cecconi; Daniel De Backer; Massimo Antonelli; Richard Beale; Jan Bakker; Christoph Hofer; Roman Jaeschke; Alexandre Mebazaa; Michael R Pinsky; Jean Louis Teboul; Jean Louis Vincent; Andrew Rhodes
Journal: Intensive Care Med Date: 2014-11-13 Impact factor: 17.440

6 in total

What's new in hemorrhagic shock?

Review 1. Practical application of point-of-care coagulation testing to guide treatment decisions in trauma.

2. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.

Review 3. Clinical review: Fresh frozen plasma in massive bleedings - more questions than answers.

4. Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy.

5. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study.

6. The relationship of blood product ratio to mortality: survival benefit or survival bias?

7. Central venous oxygen saturation and carbon dioxide gap as resuscitation targets in a hemorrhagic shock.

8. Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage.

Review 9. Clinical review: Canadian National Advisory Committee on Blood and Blood Products--Massive transfusion consensus conference 2011: report of the panel.

10. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine.

1. Focus on transfusion, bleeding and thrombosis.

2. Intensive care medicine in 2050: perioperative critical care.

3. ICM focus on thrombosis and bleeding.

4. Individualized goal directed perioperative care - the way to go!

5. Effect of gelatin-polysuccinat on cerebral oxygenation and microcirculation in a porcine haemorrhagic shock model.

6. Fluid resuscitation-related coagulation impairment in a porcine hemorrhagic shock model.